[Federal Register Volume 64, Number 143 (Tuesday, July 27, 1999)]
[Notices]
[Page 40603]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 99-19086]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Notice of Workshop; The National Vaccine Program Office, National 
Vaccine Advisory Committee Announces the Following Workshop.

    Name: Thimerasol in Vaccines.
    Times and Dates: 9 a.m.-5 p.m., August 11, 1999, 9 a.m.-1 p.m., 
August 12, 1999.
    Place: National Institutes of Health, Lister Hill Auditorium, 
Bethesda, Maryland.
    Status: Open to the public, limited only by the space available.
    Purpose: The agenda will include discussions on thimerasol in 
vaccines and its reduction and elimination from vaccines. Agenda items 
are subject to change as priorities dictate.
    Notice: In the interest of security, the Department has instituted 
stringent procedures for entrance to the National Institutes of Health 
by non-government employees. Thus, persons without a government 
identification card should plan to arrive at the building each day 
either between 8 and 8:30 a.m. or 12:30 and 1 p.m. so they can be 
escorted to the meeting. Entrance to the meeting at other times during 
the day cannot be assured.
    Contact Person for More Information: Alicia Postema, National 
Vaccine Program Office, CDC, 1600 Clifton Road, NE, M/S A-11, Atlanta, 
Georgia 30333, telephone 404/639-4450.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both CDC and ATSDR.

    Dated: July 20, 1999.
Carolyn J. Russell,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention (CDC).
[FR Doc. 99-19086 Filed 7-26-99; 8:45 am]
BILLING CODE 4163-18-P